查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561423

2024-2032 年按类型、製造商类型、合成技术、给药途径、应用和地区分類的胜肽治疗市场报告

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023年全球胜肽治疗IMARC Group规模达428亿美元。

胜肽是有效的选择性讯号分子，可与特定的细胞表面受体（例如离子通道和 G 蛋白偶联受体 (GPCR)）结合并触发细胞内效应。他们在製药业受僱设计新型再生疗法，可以针对多种细胞并操纵它们的反应。与其他治疗方案相比，这些疗法毒性较小、相对安全且耐受性良好。因此，它们在世界各地治疗癌症、损伤、传染病、代谢紊乱和美学问题的临床实践中越来越受欢迎。

胜肽治疗市场趋势：

急性和慢性疾病的日益流行，以及医疗设施的普及，是积极影响胜肽开发创新疗法需求的主要因素之一。此外，肽疗法用于药妆手术以减缓皮肤老化的过程。再加上人们对外表的意识不断增强以及对保持年轻健康皮肤的渴望，正在推动整容手术和胜肽疗法在世界各地的采用。除此之外，随着减少注射频率、提高稳定性和其他物理特性的新型合成策略的引入，肽疗法被广泛用于糖尿病患者的注射。这与糖尿病发病率的增加以及对快速和精确治疗方法的日益偏好相结合，正在影响胜肽疗法相对于口服药物的使用。此外，个人化和标靶治疗的新兴趋势正在催化对多功能胜肽基材料的需求。再加上开发用于治疗自体免疫和发炎疾病的新型胜肽疗法的资金不断增加，预计将创造积极的市场前景。

本报告回答的关键问题

  • 全球肽治疗市场有多大？ 2024-2032年全球胜肽治疗市场的预期成长率是多少？
  • 推动全球胜肽治疗市场的关键因素是什么？
  • COVID-19 对全球胜肽治疗市场有何影响？
  • 全球肽治疗市场按类型划分是怎样的？
  • 根据製造商类型，全球胜肽治疗市场的细分情况如何？
  • 基于合成技术的全球胜肽治疗市场的细分情况如何？
  • 根据给药途径，全球胜肽治疗市场的细分情况如何？
  • 根据应用，全球胜肽治疗市场的细分如何？
  • 全球胜肽治疗市场的关键区域有哪些？
  • 谁是全球胜肽治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球胜肽治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 创新的
    • 市场趋势
    • 市场预测
  • 通用的
    • 市场趋势
    • 市场预测

第 7 章：市场细分：按製造商类型

  • 外包
    • 市场趋势
    • 市场预测
  • 内部
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：透过合成技术

  • 固相胜肽合成
    • 市场趋势
    • 市场预测
  • 液相胜肽合成
    • 市场趋势
    • 市场预测
  • 混合技术
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：依管理途径

  • 注射用
    • 市场趋势
    • 市场预测
  • 口服
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按应用

  • 胃肠道疾病
    • 市场趋势
    • 市场预测
  • 神经系统疾病
    • 市场趋势
    • 市场预测
  • 代谢紊乱
    • 市场趋势
    • 市场预测
  • 癌症
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amgen Inc.
    • Apitope International NV
    • Arch Biopartners Inc.
    • AstraZeneca plc
    • Circle Pharma Inc.
    • Corden Pharma GmbH
    • F. Hoffmann-La Roche AG
    • Ipsen Group
    • Lonza Group AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Teva Pharmaceuticals Industries Ltd.
    • Zealand Pharma A/S
Product Code: SR112024A4510

The global peptide therapeutics market size reached US$ 42.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 86.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.

Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Peptide Therapeutics Market Trends:

The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.

Breakup by Type:

  • Innovative
  • Generic

Breakup by Type of Manufacturer:

  • Outsourced
  • In-house

Breakup by Synthesis Technology:

  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology

Breakup by Routes of Administration:

  • Parenteral
  • Oral
  • Others

Breakup by Application:

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.

Key Questions Answered in This Report

  • 1. How big is the global peptide therapeutics market?
  • 2. What is the expected growth rate of the global peptide therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global peptide therapeutics market?
  • 4. What has been the impact of COVID-19 on the global peptide therapeutics market?
  • 5. What is the breakup of the global peptide therapeutics market based on the type?
  • 6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
  • 7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
  • 8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
  • 9. What is the breakup of the global peptide therapeutics market based on the application?
  • 10. What are the key regions in the global peptide therapeutics market?
  • 11. Who are the key players/companies in the global peptide therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peptide Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Innovative
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Generic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Manufacturer

  • 7.1 Outsourced
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In-house
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Synthesis Technology

  • 8.1 Solid Phase Peptide Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquid Phase Peptide Synthesis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hybrid Technology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Routes of Administration

  • 9.1 Parenteral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Gastrointestinal Disorders
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Neurological Disorders
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Metabolic Disorders
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Cancer
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Amgen Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Apitope International NV
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Arch Biopartners Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 AstraZeneca plc
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Circle Pharma Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Corden Pharma GmbH
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 F. Hoffmann-La Roche AG
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 SWOT Analysis
    • 16.3.8 Ipsen Group
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Lonza Group AG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Novo Nordisk A/S
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pfizer Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Teva Pharmaceuticals Industries Ltd.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zealand Pharma A/S
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2023
  • Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2023
  • Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2023
  • Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
  • Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
  • Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2024-2032
  • Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2024-2032
  • Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2024-2032
  • Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Peptide Therapeutics Market: Competitive Structure
  • Table 9: Global: Peptide Therapeutics Market: Key Players